Gene · 406962
Papers2,086
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,086
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advancements in engineered mesenchymal stem cell exosomes for chronic lung disease treatment. | J Transl Med | 2023 | 38071321 | PubTator, text mining | PubMed |
| Medication-Related Osteonecrosis of the Jaw: A Systematic Review and a Bioinformatic Analysis. | Int J Mol Sci | 2023 | 38069068 | PubTator, text mining | PubMed |
| [Mechanism of miR-186-5p Regulating PRKAA2 to Promote Ferroptosis in Lung Adenocarcinoma Cells]. | Zhongguo Fei Ai Za Zhi | 2023 | 38061883 | PubTator, text mining | PubMed |
CircATP13A1 (hsa_circ_0000919) promotes cell proliferation and metastasis and inhibits cell apoptosis in pancreatic ductal adenocarcinoma via the miR-186/miR-326/HMGA2 axis: implications for novel therapeutic targets. | Am J Cancer Res | 2023 | 38058810 | PubTator, text mining | PubMed |
| Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases. | Behav Neurol | 2023 | 38058356 | PubTator, text mining | PubMed |
| Characterization of lncRNA-associated ceRNA network to uncover novel potential biomarkers in coronary artery disease. | Medicine (Baltimore) | 2023 | 38013355 | PubTator, text mining | PubMed |
| Function and regulation of miR-186-5p, miR-125b-5p and miR-1260a in chordoma. | BMC Cancer | 2023 | 38012562 | PubTator, text mining | PubMed |
| Knockdown of Simulated-Solar-Radiation-Sensitive miR-205-5p Does Not Induce Progression of Cutaneous Squamous Cell Carcinoma In Vitro. | Int J Mol Sci | 2023 | 38003618 | PubTator, text mining | PubMed |
| Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer's Disease. | Int J Mol Sci | 2023 | 38003448 | PubTator, text mining | PubMed |
| Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis. | Cancers (Basel) | 2023 | 38001599 | PubTator, text mining | PubMed |
| A Machine Learning Model Based on microRNAs for the Diagnosis of Essential Hypertension. | Noncoding RNA | 2023 | 37987360 | PubTator, text mining | PubMed |
| The emerging role of m6A modification of non-coding RNA in gastrointestinal cancers: a comprehensive review. | Front Cell Dev Biol | 2023 | 37965577 | PubTator, text mining | PubMed |
| miRNA-381 regulates renal cancer stem cell properties and sunitinib resistance via targeting SOX4. | Biochem Biophys Rep | 2023 | 37965067 | PubTator, text mining | PubMed |
| m6A regulator-mediated methylation modification patterns and tumor microenvironment immune infiltration with prognostic analysis in esophageal cancer. | Sci Rep | 2023 | 37952076 | PubTator, text mining | PubMed |
| Unveiling Mesenchymal Stem Cells' Regenerative Potential in Clinical Applications: Insights in miRNA and lncRNA Implications. | Cells | 2023 | 37947637 | PubTator, text mining | PubMed |
| Differentially expressed miR-127, miR-150, and miR-145 in serum extracellular vesicles are novel diagnostic biomarkers of unstable angina. | Cardiovasc Diagn Ther | 2023 | 37941844 | PubTator, text mining | PubMed |
| Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer. | Sci Rep | 2023 | 37935712 | PubTator, text mining | PubMed |
| Circulating miRNAs signature on breast cancer: the MCC-Spain project. | Eur J Med Res | 2023 | 37925534 | PubTator, text mining | PubMed |
| Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer. | J Transl Med | 2023 | 37915034 | PubTator, text mining | PubMed |
| Altered expression of circular RNA in patients with cervical artery dissection. | Front Neurol | 2023 | 37909033 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406962/papers?page=5